The effect of selective serotonin and norepinephrine reuptake inhibitors on clinical outcome of COVID‐19 patients: A systematic review and meta‐analysis
Abstract Background and Aim Due to the high social and economic burden and also mortality and morbidity caused by coronavirus disease 2019 (COVID‐19) in the past few years, researchers have aimed at finding solutions to suppressing the severity of infection. Recently, selective serotonin and seroton...
Main Authors: | Dena Firouzabadi, Fatemeh Kheshti, Saeed Abdollahifard, Erfan Taherifard, Mohammad Reza Kheshti |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-11-01
|
Series: | Health Science Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/hsr2.892 |
Similar Items
-
Design and Synthesis of Arylamidine Derivatives as Serotonin/Norepinephrine Dual Reuptake Inhibitors
by: Hui Wen, et al.
Published: (2019-01-01) -
New Serotonin-Norepinephrine Reuptake Inhibitors and Their Anesthetic and Analgesic Considerations
by: David Fanelli, et al.
Published: (2021-10-01) -
Selective serotonin reuptake inhibitors may lead to improved cataract surgery outcomes in patients with amblyopia
by: Xin KZ, et al.
Published: (2019-08-01) -
Chirality of Modern Antidepressants: An Overview
by: Monica Budău, et al.
Published: (2017-12-01) -
Monoaminergic Antidepressants in the Relief of Pain: Potential Therapeutic Utility of Triple Reuptake Inhibitors (TRIs)
by: Bruno P. Guiard, et al.
Published: (2011-01-01)